Rohto Pharmaceutical Co.,Ltd.

TSE:4527 株式レポート

時価総額：JP¥626.1b

Rohto PharmaceuticalLtd マネジメント

マネジメント 基準チェック /34

Rohto PharmaceuticalLtdの CEO はYamada Kunioで、 Jun2009年に任命され、 の在任期間は 15.42年です。 の年間総報酬は¥ 212.00Mで、 89.6%給与と10.4%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の1.74%を直接所有しており、その価値は¥ 10.92B 。経営陣と取締役会の平均在任期間はそれぞれ2.7年と5.4年です。

主要情報

Yamada Kunio

最高経営責任者

JP¥212.0m

報酬総額

CEO給与比率89.6%
CEO在任期間15.4yrs
CEOの所有権1.7%
経営陣の平均在職期間2.7yrs
取締役会の平均在任期間5.4yrs

経営陣の近況

Recent updates

Rohto Pharmaceutical Co.,Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 15
Rohto Pharmaceutical Co.,Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Shares Could Be 25% Below Their Intrinsic Value Estimate

Nov 07
Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Shares Could Be 25% Below Their Intrinsic Value Estimate

These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Reasonably Well

Oct 20
These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Reasonably Well

Shareholders Should Be Pleased With Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Price

Oct 06
Shareholders Should Be Pleased With Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Price

Returns At Rohto PharmaceuticalLtd (TSE:4527) Appear To Be Weighed Down

Sep 22
Returns At Rohto PharmaceuticalLtd (TSE:4527) Appear To Be Weighed Down

Here's Why Rohto PharmaceuticalLtd (TSE:4527) Has Caught The Eye Of Investors

Aug 25
Here's Why Rohto PharmaceuticalLtd (TSE:4527) Has Caught The Eye Of Investors

Rohto Pharmaceutical Co.,Ltd. Just Missed EPS By 6.8%: Here's What Analysts Think Will Happen Next

Aug 11
Rohto Pharmaceutical Co.,Ltd. Just Missed EPS By 6.8%: Here's What Analysts Think Will Happen Next

Does Rohto PharmaceuticalLtd (TSE:4527) Have A Healthy Balance Sheet?

Jul 11
Does Rohto PharmaceuticalLtd (TSE:4527) Have A Healthy Balance Sheet?

Calculating The Fair Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

Jun 23
Calculating The Fair Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

Unpleasant Surprises Could Be In Store For Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Shares

Jun 10
Unpleasant Surprises Could Be In Store For Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Shares

Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward

May 14
Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward

These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely

Apr 03
These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely

Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching

Mar 21
Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching

Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year

Mar 07
Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year

Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

Feb 26
Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

CEO報酬分析

Rohto PharmaceuticalLtd の収益と比較して、Yamada Kunio の報酬はどのように変化したか？
日付総報酬給与会社業績
Sep 30 2024n/an/a

JP¥27b

Jun 30 2024n/an/a

JP¥30b

Mar 31 2024JP¥212mJP¥190m

JP¥31b

Dec 31 2023n/an/a

JP¥31b

Sep 30 2023n/an/a

JP¥30b

Jun 30 2023n/an/a

JP¥28b

Mar 31 2023JP¥205mJP¥183m

JP¥26b

Dec 31 2022n/an/a

JP¥26b

Sep 30 2022n/an/a

JP¥23b

Jun 30 2022n/an/a

JP¥23b

Mar 31 2022JP¥196mJP¥178m

JP¥21b

Dec 31 2021n/an/a

JP¥23b

Sep 30 2021n/an/a

JP¥21b

Jun 30 2021n/an/a

JP¥20b

Mar 31 2021JP¥185mJP¥176m

JP¥17b

Dec 31 2020n/an/a

JP¥14b

Sep 30 2020n/an/a

JP¥14b

Jun 30 2020n/an/a

JP¥15b

Mar 31 2020JP¥192mJP¥179m

JP¥15b

Dec 31 2019n/an/a

JP¥11b

Sep 30 2019n/an/a

JP¥10b

Jun 30 2019n/an/a

JP¥9b

Mar 31 2019JP¥181mJP¥173m

JP¥10b

報酬と市場: Yamadaの 総報酬 ($USD 1.37M ) は、 JP市場 ($USD 926.78K ) の同規模の企業の平均を上回っています。

報酬と収益: Yamadaの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Yamada Kunio (68 yo)

15.4yrs

在職期間

JP¥212,000,000

報酬

Mr. Yamada Kunio had been the President at Rohto Pharmaceutical Co. Ltd. since June 9, 2009 until 2019. Mr. Kunio has been the Chairman of the Board of Directors and Representative Director at Rohto Pharma...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Yamada Kunio
Chairman of the Board & CEO15.4yrsJP¥212.00m1.74%
¥ 10.9b
Masashi Sugimoto
President5.4yrsデータなし0.0075%
¥ 46.6m
Saito Masaya
EVP, CFO & Director2.7yrsデータなし0.021%
¥ 129.0m
Shinichi Kunisaki
EVP, CTO & Director2.7yrsデータなし0.018%
¥ 112.5m
Hideto Kamimura
Senior Executive Officer and General Manager of Marketing Division no dataデータなし0.0053%
¥ 32.9m
Yasunori Kawasaki
CHRO & Director1.4yrsデータなしデータなし
Hidetoshi Segi
MD, Chief Strategy Officer & Director2.7yrsデータなし0.0039%
¥ 24.7m

2.7yrs

平均在職期間

63.5yo

平均年齢

経験豊富な経営陣: 4527の経営陣は 経験豊富 であると考えられます ( 2.7年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Yamada Kunio
Chairman of the Board & CEO25.4yrsJP¥212.00m1.74%
¥ 10.9b
Masashi Sugimoto
President5.4yrsデータなし0.0075%
¥ 46.6m
Saito Masaya
EVP, CFO & Director13.4yrsデータなし0.021%
¥ 129.0m
Shinichi Kunisaki
EVP, CTO & Director14.4yrsデータなし0.018%
¥ 112.5m
Yasunori Kawasaki
CHRO & Director1.4yrsデータなしデータなし
Hidetoshi Segi
MD, Chief Strategy Officer & Director6.4yrsデータなし0.0039%
¥ 24.7m
Kimura Masanori
Standing Corporate Auditor8.4yrsデータなし0.027%
¥ 167.4m
Akie Iriyama
Independent Outside Director5.4yrsデータなしデータなし
Haruka Mera
Independent Outside Director4.4yrsデータなしデータなし
Tatsuo Uemura
Independent Outside Director2.4yrsデータなし0.00044%
¥ 2.8m
Eriko Hayashi
Independent Outside director2.4yrsデータなしデータなし
Maiko Katadae
Independent Outside Directorless than a yearデータなしデータなし

5.4yrs

平均在職期間

62.5yo

平均年齢

経験豊富なボード: 4527の 取締役会 は 経験豊富 であると考えられます ( 5.4年の平均在任期間)。